Australia and northern European countries are doing far better than North America at retaining people living with HIV in care and achieving viral suppression, according to a comprehensive survey of ‚treatment cascades‘ in high-income countries presented on Tuesday at the HIV Drug Therapy Glasgow conference.
However, even in the best-performing countries viral suppression falls short of the aspirational target recently set by UNAIDS, and the survey identified country-specific weaknesses in performance. In the United Kingdom, diagnosis of HIV infection is the major weakness preventing higher rates of viral suppression in the population living with HIV, whereas linkage to care emerged as the primary weakness in the United States.